Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancers|November 11, 2020
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted TherapiesAlberto D'Angelo, Navid Sobhani, Robert Chapman, et al.
Future Oncology (London, England)|October 7, 2017
Advances in systemic therapy for malignant mesothelioma: future perspectivesNavid Sobhani, Silvia Paola Corona, Deborah Bonazza, et al.
Cancer Treatment Reviews|June 27, 2022
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trialsNavid Sobhani, Bruna Scaggiante, Rachel Morris, et al.
Plos One|August 6, 2019
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinomaAlberto D'Angelo, Navid Sobhani, Giandomenico Roviello, et al.
Cancers|June 24, 2022
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent AutophagyDafei Chai, Shang Yuchen Shi, Navid Sobhani, et al.
Current Issues in Molecular Biology|September 22, 2022
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity StudyAlberto D'Angelo, Fabiola Giudici, Robert Chapman, et al.
Frontiers in Immunology|February 16, 2024
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospectsBowen Lu, Jing Ming Lim, Boyue Yu, et al.
Cancers|September 9, 2023
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA RepairMonica Ganzinelli, Federica Guffanti, Anna Ianza, et al.
NPJ Vaccines|August 4, 2023
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinomaNan Jiang, Yanyan Zheng, Jiage Ding, et al.
Expert Opinion on Investigational Drugs|May 3, 2018
Lenvatinib for the treatment of renal cell carcinomaGiandomenico Roviello, Silvia Paola Corona, Giovanni Bozza, et al.
Pageof 6